TILT Biotherapeutics

Bibliographic Details
Main Author: Akseli Hemminki
Format: Article
Language:English
Published: Taylor & Francis Group 2017-05-01
Series:Human Vaccines & Immunotherapeutics
Online Access:http://dx.doi.org/10.1080/21645515.2017.1298962
_version_ 1797677632242843648
author Akseli Hemminki
author_facet Akseli Hemminki
author_sort Akseli Hemminki
collection DOAJ
first_indexed 2024-03-11T22:47:09Z
format Article
id doaj.art-ada06266106847ff925bc1749d9e5a52
institution Directory Open Access Journal
issn 2164-5515
2164-554X
language English
last_indexed 2024-03-11T22:47:09Z
publishDate 2017-05-01
publisher Taylor & Francis Group
record_format Article
series Human Vaccines & Immunotherapeutics
spelling doaj.art-ada06266106847ff925bc1749d9e5a522023-09-22T08:17:49ZengTaylor & Francis GroupHuman Vaccines & Immunotherapeutics2164-55152164-554X2017-05-0113597097110.1080/21645515.2017.12989621298962TILT BiotherapeuticsAkseli Hemminki0TILT Biotherapeutics Ltdhttp://dx.doi.org/10.1080/21645515.2017.1298962
spellingShingle Akseli Hemminki
TILT Biotherapeutics
Human Vaccines & Immunotherapeutics
title TILT Biotherapeutics
title_full TILT Biotherapeutics
title_fullStr TILT Biotherapeutics
title_full_unstemmed TILT Biotherapeutics
title_short TILT Biotherapeutics
title_sort tilt biotherapeutics
url http://dx.doi.org/10.1080/21645515.2017.1298962
work_keys_str_mv AT akselihemminki tiltbiotherapeutics